What's New
Media & Press Updates
In4Derm announces a strategic partnership with an innovation-driven NASDAQ listed biotech with a >$200m Option License Agreement for first-in-class BET bromodomain therapeutics pipeline.
May 11th 2021
In4Derm
Because Skin Matters
Our approach
Delivering first in class therapies for skin disease
We specialize in the discovery of drugs, which are safe and effective, for the treatment of skin diseases including eczema, non-melanoma skin cancers and orphan skin diseases
By discovering the next generation of therapies, we hope to greatly improve the well-being of patients with these conditions.
We would love to tell you more so please contact us with your questions.
Get in Touch
In4Derm Ltd. 15 Luke Place, Dundee, DD5 3BN. Company number: SC651132